Galmed Pharmaceuticals | 20-F:年度报告/过渡报告/注册声明
04/04 16:57 (美东)
Galmed Pharmaceuticals | 6-K:外国发行人报告
03/19 16:34 (美东)
Galmed Pharmaceuticals | 6-K:外国发行人报告
03/15 09:15 (美东)
Galmed Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-CVI Investments, Inc.(9.9%),Heights Capital Management, Inc.(9.9%)
02/14 14:18 (美东)
Galmed Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%)等
02/14 09:57 (美东)
Galmed Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Allen Baharaff(6.2%),G. Yarom Medical Research Ltd.(4.5%)
02/12 16:22 (美东)
Galmed Pharmaceuticals | EFFECT:其他
2023/11/30 00:15 (美东)
Galmed Pharmaceuticals | POS AM:修改注册声明表
2023/11/22 16:48 (美东)
Galmed Pharmaceuticals | 6-K:外国发行人报告(业绩相关)
2023/11/22 16:05 (美东)
Galmed Pharmaceuticals | 6-K:外国发行人报告
2023/11/20 16:37 (美东)
Galmed Pharmaceuticals | POS AM:修改注册声明表
2023/11/01 16:15 (美东)
Galmed Pharmaceuticals | 6-K:外国发行人报告
2023/09/26 08:51 (美东)
Galmed Pharmaceuticals | 6-K:外国发行人报告
2023/09/22 16:15 (美东)
Galmed Pharmaceuticals | 6-K/A:外国发行人报告(修正)
2023/09/21 07:30 (美东)
Galmed Pharmaceuticals | 6-K:外国发行人报告
2023/09/20 16:30 (美东)
Galmed Pharmaceuticals | 6-K:外国发行人报告
2023/09/13 16:01 (美东)
Galmed Pharmaceuticals | 6-K:外国发行人报告(业绩相关)
2023/08/09 16:43 (美东)
Galmed Pharmaceuticals | 6-K:外国发行人报告
2023/08/09 16:30 (美东)
Galmed Pharmaceuticals | 6-K:外国发行人报告(业绩相关)
2023/08/02 16:30 (美东)
Galmed Pharmaceuticals | SC 13G:超过5%持股股东披露文件-CVI Investments, Inc.(9.9%),Heights Capital Management, Inc.(9.9%)
2023/07/21 10:12 (美东)
暂无数据
暂无数据